Cyclic peptides are gaining momentum in drug discovery.
They are increasingly important in drug discovery due to their synthetic accessibility and favorable biological properties. They offer a unique balance between structural complexity and design control, making them versatile tools for screening, optimization, and mechanistic studies in modern peptide-based research. Last week we covered synthesis platforms for custom cyclic peptide libraries. However, this week, we want to share its contribution to research and their range of application.
Cyclization Matters
By constraining the peptide backbone, cyclization reduces conformational flexibility. This often leads to:
- Higher binding affinity and selectivity for protein targets
- Enhanced functional activity, particularly in challenging protein-protein interactions
- Improved proteolytic stability compared to linear peptides
These features make cyclic peptides especially attractive for targets that are difficult to address with small molecules alone.
Applications in Drug Discovery
Cyclic peptides are widely used across multiple stages of medicinal research:
- Hit identification and validation: peptide libraries can probe complex or shallow binding surfaces
- Target optimization studies, enabling fine-tuning of affinity, selectivity, and stability
- Structure-activity relationship (SAR) exploration, whereby subtle sequence or ring-size changes may yield functional insights
Their modular nature allows rapid iteration, supporting efficient lead optimization workflows.
Cyclic vs. Linear: A Practical Comparison
While linear peptides remain valuable tools in immune monitoring and as reference peptides in proteomics, cyclic peptides often outperform them in drug-relevant settings. Increased metabolic stability and reduced susceptibility to enzymatic degradation can extend assay lifetimes and improve translational relevance. In many cases, cyclization also leads to improved pharmacological profiles without sacrificing synthetic flexibility.